Literature DB >> 23399857

Does specific psychopathology predict development of psychosis in ultra high-risk (UHR) patients?

Andrew Thompson1, Barnaby Nelson, Annie Bruxner, Karen O'Connor, Nilufar Mossaheb, Magenta B Simmons, Alison Yung.   

Abstract

OBJECTIVES: Studies have attempted to identify additional risk factors within the group identified as 'ultra high risk' (UHR) for developing psychotic disorders in order to characterise those at highest risk. However, these studies have often neglected clinical symptom types as additional risk factors. We aimed to investigate the relationship between baseline clinical psychotic or psychotic-like symptoms and the subsequent transition to a psychotic disorder in a UHR sample.
METHOD: A retrospective 'case-control' methodology was used. We identified all individuals from a UHR clinic who had subsequently developed a psychotic disorder (cases) and compared these to a random sample of individuals from the clinic who did not become psychotic within the sampling time frame (controls). The sample consisted of 120 patients (60 cases, 60 controls). An audit tool was used to identify clinical symptoms reported at entry to the clinic (baseline) using the clinical file. Diagnosis at transition was assessed using the Operational Criteria for Psychotic Illness (OPCRIT) computer program. The relationship between transition to a psychotic disorder and baseline symptoms was explored using survival analysis.
RESULTS: Presence of thought disorder, any delusions and elevated mood significantly predicted transition to a psychotic disorder. When other symptoms were adjusted for, only the presence of elevated mood significantly predicted subsequent transition (hazard ratio 2.69, p = 0.002). Thought disorder was a predictor of transition to a schizophrenia-like psychotic disorder (hazard ratio 3.69, p = 0.008).
CONCLUSIONS: Few individual clinical symptoms appear to be predictive of transition to a psychotic disorder in the UHR group. Clinicians should be cautious about the use of clinical profile alone in such individuals when determining who is at highest risk.

Entities:  

Mesh:

Year:  2013        PMID: 23399857     DOI: 10.1177/0004867413476753

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  11 in total

Review 1.  Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.

Authors:  Scott Richard Clark; Klaus Oliver Schubert; Bernhard Theodor Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

2.  Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.

Authors:  Charity J Morgan; Michael J Coleman; Ayse Ulgen; Lenore Boling; Jonathan O Cole; Frederick V Johnson; Jan Lerbinger; J Alexander Bodkin; Philip S Holzman; Deborah L Levy
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

3.  Does hallucination perceptual modality impact psychosis risk?

Authors:  H F Niles; B C Walsh; S W Woods; A R Powers
Journal:  Acta Psychiatr Scand       Date:  2019-08-16       Impact factor: 6.392

4.  The content of attenuated psychotic symptoms in those at clinical high risk for psychosis.

Authors:  Catherine Marshall; Erin Denny; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Scott W Woods; Elaine Walker; Jean Addington
Journal:  Psychiatry Res       Date:  2014-06-21       Impact factor: 3.222

5.  The Violent Content in Attenuated Psychotic Symptoms.

Authors:  Catherine Marshall; Stephanie Deighton; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

6.  Severity of thought disorder predicts psychosis in persons at clinical high-risk.

Authors:  Diana O Perkins; Clark D Jeffries; Barbara A Cornblatt; Scott W Woods; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Robert Heinssen; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2015-10-04       Impact factor: 4.939

7.  Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.

Authors:  S R Clark; B T Baune; K O Schubert; S Lavoie; S Smesny; S M Rice; M R Schäfer; F Benninger; M Feucht; C M Klier; P D McGorry; G P Amminger
Journal:  Transl Psychiatry       Date:  2016-09-20       Impact factor: 6.222

8.  The Reliability and Validity of Liu´s Self-Report Questionnaire for Screening Putative Pre-Psychotic States (BQSPS) in Adolescents.

Authors:  D Núñez; V B Arias; S Campos
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

9.  Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.

Authors:  Andrea Mechelli; Ashleigh Lin; Stephen Wood; Patrick McGorry; Paul Amminger; Stefania Tognin; Philip McGuire; Jonathan Young; Barnaby Nelson; Alison Yung
Journal:  Schizophr Res       Date:  2016-12-04       Impact factor: 4.939

10.  Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis.

Authors:  Marinos Kyriakopoulos; Argyris Stringaris; Sofia Manolesou; Maja Drobnič Radobuljac; Brian Jacobs; Avi Reichenberg; Daniel Stahl; Emily Simonoff; Sophia Frangou
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-06-26       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.